About Zinc finger protein 385B
Zinc finger protein 385B (ZNF385B) is a protein
from Homo sapiens identified by UniProt accession
Q569K4, 471 residues long.
MolForge cross-references it against 0 known binders and
63 disease associations.
Target properties
| Protein name | Zinc finger protein 385B |
| UniProt accession | Q569K4 |
| Gene | ZNF385B |
| Organism | Homo sapiens |
| Length | 471 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (63)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.43
- testosterone measurement · score 0.40
- sex hormone-binding globulin measurement · score 0.34
- sudden cardiac arrest · score 0.31
- pulse pressure measurement · score 0.29
- blood protein measurement · score 0.28
- mannan-binding lectin serine protease 1 measurement · score 0.28
- breast milk measurement · score 0.27
- mean platelet volume · score 0.11
- protein measurement · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q569K4-F1 | alphafold | PREDICTED | 60.48 | — |
Amino-acid sequence (471 residues)
MNMANFLRGF EEKGIKNDRP EDQLSKEKKK ILFSFCEVCN IQLNSAAQAQ VHSNGKSHRK RVKQLSDGQP PPPAQASPSS NSSTGSTCHT TTLPALVRTP TLMMQPSLDI KPFMSFPVDS SSAVGLFPNF NTMDPVQKAV INHTFGVSIP PKKKQVISCN VCQLRFNSDS QAEAHYKGSK HAKKVKALDA TKNKPKMVPS KDSAKANPSC SITPITGNNS DKSEDKGKLK ASSSSQPSSS ESGSFLLKSG TTPLPPGAAT SPSKSTNGAP GTVVESEEEK AKKLLYCSLC KVAVNSLSQL EAHNTGSKHK TMVEARNGAG PIKSYPRPGS RLKMQNGSKG SGLQNKTFHC EICDVHVNSE IQLKQHISSR RHKDRVAGKP LKPKYSPYNK LQRSPSILAA KLAFQKDMMK PLAPAFLSSP LAAAAAVSSA LSLPPRPSAS LFQAPAIPPA LLRPGHGPIR ATPASILFAP Y
Explore Zinc finger protein 385B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets